Lan Lin

622 total citations
9 papers, 318 citations indexed

About

Lan Lin is a scholar working on Epidemiology, Surgery and Health. According to data from OpenAlex, Lan Lin has authored 9 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Surgery and 1 paper in Health. Recurrent topics in Lan Lin's work include Hepatitis B Virus Studies (8 papers), Cervical Cancer and HPV Research (8 papers) and Genital Health and Disease (7 papers). Lan Lin is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Cervical Cancer and HPV Research (8 papers) and Genital Health and Disease (7 papers). Lan Lin collaborates with scholars based in Belgium, United States and Colombia. Lan Lin's co-authors include Frank Struyf, Gary Dubin, Nahida Chakhtoura, Archana Chatterjee, Mark H. Einstein, Péter Takács, Tino F. Schwarz, P.V. Suryakiran, Nicolas Folschweiller and Mark M. Blatter and has published in prestigious journals such as Vaccine, The Pediatric Infectious Disease Journal and Human Vaccines & Immunotherapeutics.

In The Last Decade

Lan Lin

9 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lan Lin Belgium	8	282	88	83	27	26	9	318
Bernal Cortés Costa Rica	9	220 0.8×	86 1.0×	55 0.7×	21 0.8×	57 2.2×	15	309
Mirte Scherpenisse Netherlands	11	289 1.0×	130 1.5×	84 1.0×	33 1.2×	31 1.2×	12	340
Erin Moeller United States	6	233 0.8×	83 0.9×	62 0.7×	13 0.5×	15 0.6×	7	259
Amha Tadesse United States	11	316 1.1×	126 1.4×	72 0.9×	22 0.8×	58 2.2×	11	366
Johanna Palmroth Finland	9	320 1.1×	137 1.6×	55 0.7×	26 1.0×	25 1.0×	12	344
Tiina Petäjä Finland	7	509 1.8×	190 2.2×	140 1.7×	29 1.1×	33 1.3×	13	556
Roger Maansson United States	9	386 1.4×	109 1.2×	61 0.7×	14 0.5×	129 5.0×	20	425
Tiequn Zhou Switzerland	9	266 0.9×	95 1.1×	49 0.6×	13 0.5×	47 1.8×	14	384
Sara Cecilia Soto‐De León Colombia	14	293 1.0×	118 1.3×	29 0.3×	6 0.2×	82 3.2×	25	364
Aaron Ermel United States	12	247 0.9×	94 1.1×	19 0.2×	11 0.4×	133 5.1×	37	346

Countries citing papers authored by Lan Lin

Since Specialization

Citations

This map shows the geographic impact of Lan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Lin more than expected).

Fields of papers citing papers by Lan Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Lin. The network helps show where Lan Lin may publish in the future.

Co-authorship network of co-authors of Lan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Lin. A scholar is included among the top collaborators of Lan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Lin. Lan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Schwarz, Tino F., Li‐Min Huang, Alejandra Valencia, et al.. (2019). A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years. Human Vaccines & Immunotherapeutics. 15(7-8). 1970–1979. 45 indexed citations

Lin, Lan, et al.. (2019). Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus–16/18 Vaccine in Four- to Six-year-old Girls. The Pediatric Infectious Disease Journal. 38(10). 1061–1067. 10 indexed citations

Lin, Lan, et al.. (2018). Safety and Immunogenicity of the HPV-16/18 AS04-adjuvanted Vaccine in 4–6-year-old Girls. The Pediatric Infectious Disease Journal. 37(4). e93–e102. 9 indexed citations

Willame, Corinne, Ouzama Henry, Lan Lin, et al.. (2017). Pain caused by measles, mumps, and rubella vaccines: A systematic literature review. Vaccine. 35(42). 5551–5558. 2 indexed citations

Schwarz, Tino F., Andrzej Gałaj, Marek Spaczyński, et al.. (2017). Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age. Cancer Medicine. 6(11). 2723–2731. 58 indexed citations

Schwarz, Tino F., Li‐Min Huang, Tzou‐Yien Lin, et al.. (2014). Long-term Immunogenicity and Safety of the HPV-16/18 AS04-adjuvanted Vaccine in 10- to 14-year-old Girls. The Pediatric Infectious Disease Journal. 33(12). 1255–1261. 21 indexed citations

Einstein, Mark H., Myron J. Levin, Archana Chatterjee, et al.. (2014). Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18–45 years: Follow-up through Month 48 in a Phase III randomized study. Human Vaccines & Immunotherapeutics. 10(12). 3455–3465. 50 indexed citations

Konno, Ryo, Hiroyuki Yoshikawa, Wim Quint, et al.. (2014). Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia and cervical infection in young Japanese women. Human Vaccines & Immunotherapeutics. 10(7). 1781–1794. 27 indexed citations

Einstein, Mark H., Péter Takács, Archana Chatterjee, et al.. (2014). Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: End-of-study analysis of a Phase III randomized trial. Human Vaccines & Immunotherapeutics. 10(12). 3435–3445. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact